What is the patient acquisition cost for a plastic surgery practice in India?

Why the lead cost isn't the number that matters

A practice paying more per enquiry but converting a high share of consultations into booked surgeries will beat a practice with cheaper leads and weak follow-through, every time. Plastic surgery patients aren't comparing clinics the way a dental or diagnostics patient might. They're comparing surgeons, on trust, credentials and outcomes they've seen elsewhere, and a cheap lead that never converts costs more in the end than an expensive one that does.

What patients actually do before they enquire

Months of research typically precede a single enquiry. A prospective patient will watch a surgeon's videos, read reviews, cross-check credentials, and often consult more than one practice before booking anything, which is exactly why this category behaves differently from transactional healthcare verticals where price comparison drives the decision. Trust accumulates slowly here, and no amount of lead volume substitutes for it.

The conversion stages that actually set the cost

Three numbers matter more than CPQL: how many enquiries become booked consultations, how many consultations become booked surgeries, and how long that whole cycle takes. A practice with a 15% enquiry-to-consultation rate and a strong consultation-to-surgery close rate is in a completely different financial position than one converting half as well, even at an identical lead cost. Tracking these stages, not just the top-of-funnel number, is what turns acquisition cost into a usable metric in this specialty.

What an acceptable acquisition cost looks like

Because ticket sizes run high and cash-pay, this category can sustain a materially higher acquisition cost than most other specialties and still be profitable, provided consultation conversion holds up. The ceiling isn't a benchmark CPQL, it's the margin on the procedure itself once consultation and surgery conversion are factored in. A practice should be building its own acceptable-cost number from its actual conversion data rather than importing a specialty-agnostic average.

For the budget side of this, what an agency fee, media spend and compliant creative production actually cost, see how much plastic surgery marketing costs. For the broader specialty context, ICG's plastic surgery industry practice and healthcare marketing agency pages both start from this conversion-first framing rather than a lead-cost target.

Frequently asked questions

Is there a benchmark CPQL for plastic surgery? No verified one in ICG's authoritative data. Use the national average of ₹2,750 as a reference only, not a target.

Why doesn't a low cost per lead guarantee good acquisition economics here? Because plastic surgery converts on trust over a long window. A cheap lead that never books a consultation, or a consultation that never books surgery, costs more in the end than a pricier lead that converts.

What conversion rate should a practice expect from enquiry to consultation? There's no single industry figure to quote reliably, so a practice should track its own rate and treat it as the number to improve, not compare against an external benchmark.

Does a higher acquisition cost make sense for plastic surgery than other specialties? Yes, within reason. High ticket size and cash-pay economics mean this category can absorb a higher acquisition cost per patient than lower-value specialties and remain profitable.

How is this different from marketing cost? Marketing cost is what a practice spends on agency fees, media and production. Acquisition cost is what that spend returns per patient once conversion through consultation and surgery is factored in. See plastic surgery marketing cost for the spend side.

Written by Raman Soni. Reviewed by Abhash Kumar, Co-Founder, Strategy.

Detailed answers